AR066005A1 - Un metodo para la preparacion de un enantiomero de una benzazepina tetraciclica - Google Patents
Un metodo para la preparacion de un enantiomero de una benzazepina tetraciclicaInfo
- Publication number
- AR066005A1 AR066005A1 ARP080101475A AR066005A1 AR 066005 A1 AR066005 A1 AR 066005A1 AR P080101475 A ARP080101475 A AR P080101475A AR 066005 A1 AR066005 A1 AR 066005A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- preparation
- ketone
- mirtazapine
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- DQFQCHIDRBIESA-UHFFFAOYSA-N 1-benzazepine Chemical compound N1C=CC=CC2=CC=CC=C12 DQFQCHIDRBIESA-UHFFFAOYSA-N 0.000 title 1
- -1 carboxylic acid compound Chemical class 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000002440 hydroxy compounds Chemical class 0.000 abstract 3
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 abstract 3
- 229960001785 mirtazapine Drugs 0.000 abstract 3
- 239000003638 chemical reducing agent Substances 0.000 abstract 2
- 125000002843 carboxylic acid group Chemical group 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07105985 | 2007-04-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR066005A1 true AR066005A1 (es) | 2009-07-15 |
Family
ID=38474342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080101475 AR066005A1 (es) | 2007-04-11 | 2008-04-10 | Un metodo para la preparacion de un enantiomero de una benzazepina tetraciclica |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2146993B1 (OSRAM) |
| JP (1) | JP5635905B2 (OSRAM) |
| CN (1) | CN101679431B (OSRAM) |
| AR (1) | AR066005A1 (OSRAM) |
| CA (1) | CA2684021A1 (OSRAM) |
| MX (1) | MX2009010967A (OSRAM) |
| WO (1) | WO2008125578A2 (OSRAM) |
| ZA (1) | ZA200907537B (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012133486A1 (ja) * | 2011-03-31 | 2012-10-04 | 株式会社カネカ | 環状アミン化合物の製造法 |
| PL3261645T3 (pl) | 2015-02-27 | 2021-12-06 | Dechra Limited | Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| US6303595B1 (en) | 1997-11-14 | 2001-10-16 | Akzo Nobel N.V. | Use of mirtazapine for treating sleep apneas |
| HK1044116A1 (zh) | 1999-04-19 | 2002-10-11 | Teva Pharmaceutical Industries Limited | 含哌嗪环化合物的新型合成和结晶方法 |
| AU6476300A (en) | 1999-09-30 | 2001-05-10 | Sumika Fine Chemicals Co., Ltd. | Process for the preparation of a piperazine derivative |
| WO2001042239A1 (en) | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Process for the preparation of a pyridinemethanol compound |
| EP1656937A1 (en) | 2000-02-11 | 2006-05-17 | Akzo Nobel N.V. | The use of mirtazapine for the treatment of sleep disorders |
| HUP0401921A3 (en) | 2001-09-14 | 2008-03-28 | Medichem Sa | Intermediate compounds for the preparation of mirtazapine and the production methods thereof |
| US6806283B2 (en) * | 2002-05-06 | 2004-10-19 | Virginia Commonwealth University | Selective serotonin receptor antagonists and therapeutic applications thereof |
| UA83666C2 (ru) * | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
| EP2514756B1 (en) * | 2003-08-01 | 2014-12-17 | Mitsubishi Tanabe Pharma Corporation | Novel compounds having inhibitory activity against sodium-dependant glucose transporter |
| JP2007284358A (ja) | 2006-04-13 | 2007-11-01 | Sumitomo Chemical Co Ltd | 光学活性なピペラジン化合物の製造方法 |
| TW200815370A (en) * | 2006-06-16 | 2008-04-01 | Organon Nv | Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine |
-
2008
- 2008-04-10 WO PCT/EP2008/054316 patent/WO2008125578A2/en not_active Ceased
- 2008-04-10 MX MX2009010967A patent/MX2009010967A/es not_active Application Discontinuation
- 2008-04-10 AR ARP080101475 patent/AR066005A1/es unknown
- 2008-04-10 CA CA002684021A patent/CA2684021A1/en not_active Abandoned
- 2008-04-10 JP JP2010502504A patent/JP5635905B2/ja active Active
- 2008-04-10 EP EP08736038.4A patent/EP2146993B1/en active Active
- 2008-04-10 CN CN200880016144.9A patent/CN101679431B/zh active Active
-
2009
- 2009-10-27 ZA ZA200907537A patent/ZA200907537B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101679431B (zh) | 2013-08-14 |
| ZA200907537B (en) | 2010-07-28 |
| CN101679431A (zh) | 2010-03-24 |
| EP2146993A2 (en) | 2010-01-27 |
| CA2684021A1 (en) | 2008-10-23 |
| WO2008125578A3 (en) | 2008-12-24 |
| JP2010523620A (ja) | 2010-07-15 |
| WO2008125578A2 (en) | 2008-10-23 |
| MX2009010967A (es) | 2009-12-15 |
| EP2146993B1 (en) | 2015-08-05 |
| JP5635905B2 (ja) | 2014-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016000982A1 (es) | Compuestos derivados de 1,4-dihidrocromeno[4,3-c]-pirazol, 1h-pirazol[4,3-f o 3,4-f]-quinolina, 1h-benzo[g]-indazol, que median una afección por fxr; composiciones y combinaciones farmacológicas; útiles para el tratamiento de una enfermedad hepática, tales como colestasis intrahepática, inducida por los estrógenos, por fármacos, inducida por fármacos, asociada al embarazo, asociada a nutrición parenteral, entre otras. | |
| UY32456A (es) | Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento | |
| AR110128A2 (es) | Compuesto del grupo de las 3-(imidazoil)-pirazolo[3,4-b]piridinas, composición farmacéutica que lo comprende y método para preparar el mismo | |
| CL2009001766A1 (es) | Composicion farmaceutica solida para administracion oral que comprende: un taxano sustancialmente amorfo definido, un portador hidrofilico definido y un tensoactivo definido; metodo para preparar la composicion; y su uso para tratar una enfermedad neoplasica. | |
| CL2011001331A1 (es) | Clorhidrato de nalmefeno dihidratado; métodos para su preparación; composición farmacéutica que lo comprende; y uso para el tratamiento del alcoholismo. | |
| ECSP11011387A (es) | Anticuerpos biespecíficos anti-erbb-3/anti-c-met | |
| BRPI0814811A2 (pt) | Composto, agente, método, e composição de diagnóstico, uso de um composto, e, método de formação de imagem | |
| WO2009047644A3 (en) | Method of treating vitamin d insufficiency and deficiency | |
| WO2007098128A3 (en) | Phenylephrine-containing liquid formulations | |
| AR076194A1 (es) | Anticuerpos biespecificos anti-erbb-2/anti-c-met | |
| BRPI0910072A2 (pt) | composto, composição farmaceutic, e, método para prover anestesia a um mamífero. | |
| CL2012000258A1 (es) | Proceso para la preparacion de composicion de aglomerante hidraulico asperjable que contiene como principales componentes agua, agregados, aglomerante hidraulico, acelerador de fraguado, aglomerante hidraulico asperjable; composicion; y uso | |
| WO2010031720A3 (en) | Novel antibody formulation | |
| PH12012501052A1 (en) | Novel spiropiperidine compounds | |
| BR112012011328A2 (pt) | inibidores de akt | |
| CL2008001783A1 (es) | Acido desoxicolico (dca); composicion farmaceutica que lo comprende; procedimiento de preparacion de acido desoxicolico; compuestos intermediarios, utiles en la preparacion de un medicamento para remover depositos de grasa. | |
| BRPI0923291A2 (pt) | processo para a destilação de uma mistura aquosa de polimetilol, composição, e, uso de um polimetilol. | |
| CO6300903A2 (es) | Preparacion de formas farmaceuticas relajantes de musculos esqueleticos de liberacion controlada | |
| BRPI0912539A2 (pt) | composto, composição farmacêutica , método para tratar uma doença, e, uso do composto. | |
| CL2008001048A1 (es) | Compuestos derivados de heterociclos nitrogenados; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto como antibacterianos. | |
| BR112012004173A2 (pt) | "composto, composição, método para preparar uma composição, e, uso de um composto" | |
| CL2009001298A1 (es) | Compuestos derivados de n-ciclohexil-2-fenoxinicotinamida; composición farmcéutica que los comprende; combinación farmacéutica que los comprende; y su uso para tratar una enfermedad mediada por la pde4. | |
| WO2009098716A3 (en) | Stabilized aqueous formulation containing paracetamol | |
| CL2008003095A1 (es) | Procedeimiento de preparacion de dihidrotienopirimidas; uno de los compuestos intermediarios considerados; y el procedimiento de preparacion de dicho compuesto intermediario. | |
| BRPI0812845A2 (pt) | Método para a preparação de uma composição compreendendo um absorvedor de uv orgânico insolúvel micronizado. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |